Label: CONJU PRINCESS UV SUN BLOCK- ethylhexyl methoxycinnamate cream

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated December 18, 2010

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    active ingredients: Ethylhexyl methoxycinnamate, 4-methylbenzylidene camphor, butyl methoxydibenzoylmethane, titanium dioxide, zinc oxide
  • INACTIVE INGREDIENT

    inactive ingredient: water, cyclopentasiloxane, dipropylene glycol, glycerin, dimethicone, hexyl laurate, sorbitan olivate, sorbitan sesquioleate, magnesium sulfate, stearic acid, hectorite, aluminum hydroxide, phenoxyethanol, propylparaben, methylparaben, disodium EDTA, fragrance
  • PURPOSE

    Recommended for sensitive skin that needs virtually total sunblock protection
  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children
  • INDICATIONS & USAGE

    Apply daily, with or without make-up to exposed areas
  • WARNINGS

    Avoid eye area. If contact occurs, rinse eyes thoroughly with water.
    If  following abnormal symptoms (red specks, swelling, itching) occurs after use, stop use and ask doctor.
  • DOSAGE & ADMINISTRATION

    Apply daily, with or without make-up to exposed areas
  • PRINCIPAL DISPLAY PANEL

    package label
  • INGREDIENTS AND APPEARANCE
    CONJU PRINCESS UV SUN BLOCK 
    ethylhexyl methoxycinnamate cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:59915-2001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE0.075 mL  in 1 mL
    ENZACAMENE (UNII: 8I3XWY40L9) (ENZACAMENE - UNII:8I3XWY40L9) ENZACAMENE0.05 mL  in 1 mL
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE0.0249 mL  in 1 mL
    AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE0.03 mL  in 1 mL
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE0.01 mL  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
    DIPROPYLENE GLYCOL (UNII: E107L85C40)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    HEXYL LAURATE (UNII: 4CG9F9W01Q)  
    SORBITAN OLIVATE (UNII: MDL271E3GR)  
    SORBITAN SESQUIOLEATE (UNII: 0W8RRI5W5A)  
    MAGNESIUM SULFATE, UNSPECIFIED (UNII: DE08037SAB)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    HECTORITE (UNII: 08X4KI73EZ)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:59915-2001-150 mL in 1 TUBE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other12/18/2010
    Labeler - Conju Inc (012345486)
    Registrant - Conju Inc (012345486)
    Establishment
    NameAddressID/FEIBusiness Operations
    Costree Co., Ltd690345835manufacture
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!